Home About

TL;DR CNBC


As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data - TL;DR CNBC

As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data

Publishing timestamp: 2023-10-24 06:00:01


Summary

Wearable startup Signos has closed a $20 million funding round led by Cheyenne Ventures and GV. The company's platform uses data from continuous glucose monitors (CGMs) to provide real-time diet and exercise recommendations for weight loss. Signos aims to help individuals understand their metabolism and make better choices for their bodies. The funding will be used to continue research into metabolic health and expand the team.


Sentiment: NEUTRAL

Tickers: DXCM,  AAPL,  NOVO.B-DK,  GOOGL,  ABT, 

Keywords: health care industry,  novo nordisk a/s,  abbott laboratories,  technology,  breaking news: technology,  weight management,  enterprise,  dexcom inc,  alphabet inc,  business news,  apple inc, 

Source: https://www.cnbc.com/2023/10/24/signos-raised-20-million-to-tackle-weight-loss-with-cgms-and-data.html


Developed by Leo Phan